Erasca, Inc. Public Float
Erasca, Inc. (ERAS) had Public Float of $316.40 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $316.40M.
- 2024-06-28: Entity Public Float $562.90M.
- 2023-06-30: Entity Public Float $297.00M.
- 2022-06-30: Entity Public Float $431.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $316.40M 10-K · filed 2026-03-12 |
| 2024-06-28 | $562.90M 10-K · filed 2025-03-20 |
| 2023-06-30 | $297.00M 10-K · filed 2024-03-27 |
| 2022-06-30 | $431.60M 10-K · filed 2023-03-23 |
| 2021-07-20 | $1.10B 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |